These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 3039015)
21. Cell and virus sensitivity studies with recombinant human alpha interferons. Kramer MJ; Dennin R; Kramer C; Jones G; Connell E; Rolon N; Gruarin A; Kale R; Trown PW J Interferon Res; 1983; 3(4):425-35. PubMed ID: 6323591 [TBL] [Abstract][Full Text] [Related]
22. Anti-herpesvirus activity of adenine arabinoside analogues in tissue culture and a genital infection of mice and guinea pigs. Richards JT; Kern ER; Overall JC; Glasgow LA Antiviral Res; 1982 May; 2(1-2):27-39. PubMed ID: 6179469 [TBL] [Abstract][Full Text] [Related]
23. Inhibitory effect of Azone (1-dodecylazacycloheptan-2-one) on herpes simplex viruses. In vivo and in vitro studies. Leonard MF; Kumar A; Murray DL; Beaman DC Chemotherapy; 1987; 33(2):151-6. PubMed ID: 3032527 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of aerosolized recombinant interferons against vesicular stomatitis virus-induced lung infection in cotton rats. Sun CS; Wyde PR; Wilson SZ; Knight V J Interferon Res; 1984; 4(4):449-59. PubMed ID: 6094681 [TBL] [Abstract][Full Text] [Related]
25. Antitumor effect of combined intraperitoneal administration of human recombinant interferon-beta and interferon-gamma against intraabdominal carcinomatosis in nude mice. Kondo H; Tanaka N; Naomoto Y; Orita K Acta Med Okayama; 1988 Apr; 42(2):69-75. PubMed ID: 3133927 [TBL] [Abstract][Full Text] [Related]
27. Acyclovir treatment of experimental genital herpes simplex virus infections. Kern ER Am J Med; 1982 Jul; 73(1A):100-8. PubMed ID: 6285699 [TBL] [Abstract][Full Text] [Related]
28. Effect of recombinant mouse interferon-beta on acute and latent herpes simplex infection in mice. Yamada M; Arao Y; Hatano A; Uno F; Nii S Arch Virol; 1988; 99(1-2):101-9. PubMed ID: 3355371 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of antioxidant healing formulations in topical therapy of experimental cutaneous and genital herpes simplex virus infections. Sheridan J; Kern E; Martin A; Booth A Antiviral Res; 1997 Dec; 36(3):157-66. PubMed ID: 9477116 [TBL] [Abstract][Full Text] [Related]
30. Influence of vehicle on topical efficacy of 2-acetylpyridine thiosemicarbazone and related derivatives on in vivo type 2 herpes simplex virus infections. Sidwell RW; Huffman JH; Schafer TW; Shipman C Chemotherapy; 1990; 36(1):58-69. PubMed ID: 2155092 [TBL] [Abstract][Full Text] [Related]
31. Changes in lymphocyte subsets following multiple administration of recombinant interleukin-2 plus recombinant interferon-beta or -gamma in tumor-bearing mice. Iigo M; Nishikata K; Nakajima Y; Moriyama M Jpn J Cancer Res; 1989 Jun; 80(6):554-61. PubMed ID: 2527216 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic effect of pyrophosphate analogues on cutaneous herpes simplex virus type 1 infection in guinea pigs. Wutzler P; Helbig B; Ulbricht A; Meerbach A; Pradel W Antiviral Res; 1988 Nov; 10(1-3):99-106. PubMed ID: 2852923 [TBL] [Abstract][Full Text] [Related]
33. Differential in vitro effects of recombinant alpha-interferon and recombinant gamma-interferon alone or in combination on the expression of melanoma-associated surface antigens. Murray JL; Stuckey SE; Pillow JK; Rosenblum MG; Gutterman JU J Biol Response Mod; 1988 Apr; 7(2):152-61. PubMed ID: 3129542 [TBL] [Abstract][Full Text] [Related]
34. Synergism between recombinant human interferon and nucleoside antiviral agents against herpes simplex virus: examination with an automated microtiter plate assay. Moran DM; Kern ER; Overall JC J Infect Dis; 1985 Jun; 151(6):1116-22. PubMed ID: 2987369 [TBL] [Abstract][Full Text] [Related]
35. Value of the dorsal cutaneous guinea pig model in selecting topical antiviral formulations for the treatment of recurrent herpes simplex type 1 disease. Poli G; Dall'Ara P; Binda S; Santus G; Poli A; Cocilovo A; Ponti W Arzneimittelforschung; 2001; 51(5):433-8. PubMed ID: 11413746 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of topical treatment for herpes simplex virus infections: predictions from an index of drug characteristics in vitro. Freeman DJ; Spruance SL J Infect Dis; 1986 Jan; 153(1):64-70. PubMed ID: 3079810 [TBL] [Abstract][Full Text] [Related]
37. Effects of cytokines and R-837, a cytokine inducer, on UV-irradiation augmented recurrent genital herpes in guinea pigs. Harrison CJ; Stanberry LR; Bernstein DI Antiviral Res; 1991 May; 15(4):315-22. PubMed ID: 1659313 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs. Bravo FJ; Stanberry LR; Kier AB; Vogt PE; Kern ER Antiviral Res; 1993 May; 21(1):59-72. PubMed ID: 8391249 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs. Alenius S; Berg M; Broberg F; Eklind K; Lindborg B; Oberg B J Infect Dis; 1982 Apr; 145(4):569-73. PubMed ID: 6279738 [TBL] [Abstract][Full Text] [Related]
40. Oral and topical treatment of experimental HSV-1 genital herpes with (E)-5-(2-bromovinyl)-2'-deoxyuridine. Sim IS J Antimicrob Chemother; 1984 Aug; 14 Suppl A():111-8. PubMed ID: 6541647 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]